Skip to content

A study to evaluate the effectiveness of the test product in improving scalp health over a period of 4 weeks.

A clinical study to evaluate the safety and efficacy of the test product in improving scalp health over 4 weeks in comparison to baseline. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082878
Enrollment
90
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: LC-SL-1045/020: sufficient amount of test product to be applied all over the head, hair and scalp followed by Washing in a standardized manner. Product application will be based on subj

Sponsors

LiquidCubes InnoCommerce (LiquidCubes)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Male subjects in general good health with scalp conditions (Dry, Itchy, Irritated, Redness, Flaking) 2) Subjects in the age group 18-45 years (both ages inclusive). 3) Subjects with moderate flakes. 4) Subjects willing to give written informed consent and willing to abide by and comply with the study protocol. 5) Subjects willing to refrain from using any other product that can impact scalp health.

Exclusion criteria

Exclusion criteria: 1) Subjects having any active scalp disease which may interfere with the study based on the dermatologist s discretion. 2) Subjects who have taken chemotherapy for cancer in the 6 months prior to the start of the study. 3) Subjects who have undergone hair transplants. 4) A known history or present condition of allergic response/hypersensitivity to any hair or pharmaceutical products. 5) Subjects on oral medications like topical or systemic corticosteroids, anti-fungal, or antibiotics, or any prolonged use of non-steroidal anti-inflammatory, or anti-histaminic within 2 weeks prior to the study, undergoing any chemical hair salon treatment-straightening / perming/color/henna which will compromise the study. 6) Subjects participating in other similar trials within the last 2 weeks. 7) Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, thyroid, hepatitis, severe anemia, serious disorder of the heart and respiratory apparatus or any other serious medical illness 8) Employees of MSCR or the sponsor.

Design outcomes

Primary

MeasureTime frame
1)Improvement of scalp health/condition and significant reduction of the total dandruff score, Non-Adherent and Adherent flakes score evaluated by Visual assessment. 2)Reduction in oiliness and Improved scalp hydration by non-invasive instrumental assessment. 3)Efficacy of the test product in reducing flakes using the Visible Flake Assessment. 4)Change of microbiome of the scalp by product usage at week 4. 5)Improved scalp condition by microscopic imaging. Timepoint: Baseline, week 2 and week 4

Secondary

MeasureTime frame
1) Improved scalp health by Subject self-assessment.Timepoint: Baseline, week 2 and week 4

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd.

mukta.sachdev@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026